Tabrizi M - Search Results

1

Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial.

Mohammadi MR, Kazemi MR, Zia E, Rezazadeh SA, Tabrizi M, Akhondzadeh S. Mohammadi MR, et al. Among authors: tabrizi m. Hum Psychopharmacol. 2010 Nov;25(7-8):560-5. doi: 10.1002/hup.1154. Epub 2010 Dec 8. Hum Psychopharmacol. 2010. PMID: 21312290 Clinical Trial.

2

Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.

Rezaei V, Mohammadi MR, Ghanizadeh A, Sahraian A, Tabrizi M, Rezazadeh SA, Akhondzadeh S. Rezaei V, et al. Among authors: tabrizi m. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1269-72. doi: 10.1016/j.pnpbp.2010.07.005. Epub 2010 Jul 14. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 20637249 Clinical Trial.

3

Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.

Zarinara AR, Mohammadi MR, Hazrati N, Tabrizi M, Rezazadeh SA, Rezaie F, Akhondzadeh S. Zarinara AR, et al. Among authors: tabrizi m. Hum Psychopharmacol. 2010 Nov;25(7-8):530-5. doi: 10.1002/hup.1148. Epub 2010 Sep 22. Hum Psychopharmacol. 2010. PMID: 20860068 Clinical Trial.

4

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial.

Akhondzadeh S, Ghayyoumi R, Rezaei F, Salehi B, Modabbernia AH, Maroufi A, Esfandiari GR, Naderi M, Ghebleh F, Tabrizi M, Rezazadeh SA. Akhondzadeh S, et al. Among authors: tabrizi m. Psychopharmacology (Berl). 2011 Feb;213(4):809-15. doi: 10.1007/s00213-010-2044-z. Epub 2010 Oct 15. Psychopharmacology (Berl). 2011. PMID: 20949350 Clinical Trial.

5

Acetyl-L-carnitine as an adjunctive therapy in the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a placebo-controlled trial.

Abbasi SH, Heidari S, Mohammadi MR, Tabrizi M, Ghaleiha A, Akhondzadeh S. Abbasi SH, et al. Among authors: tabrizi m. Child Psychiatry Hum Dev. 2011 Jun;42(3):367-75. doi: 10.1007/s10578-011-0220-y. Child Psychiatry Hum Dev. 2011. PMID: 21336630 Clinical Trial.

6

Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trial.

Ghaleiha A, Honarbakhsh N, Boroumand MA, Jafarinia M, Tabrizi M, Rezaei F, Raznahan M, Akhondzadeh S. Ghaleiha A, et al. Among authors: tabrizi m. Hum Psychopharmacol. 2011 Mar;26(2):120-4. doi: 10.1002/hup.1176. Epub 2011 Mar 16. Hum Psychopharmacol. 2011. PMID: 21412846 Clinical Trial.

7

A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia.

Arbabi M, Bagheri M, Rezaei F, Ahmadi-Abhari SA, Tabrizi M, Khalighi-Sigaroudi F, Akhondzadeh S. Arbabi M, et al. Among authors: tabrizi m. Psychopharmacology (Berl). 2012 Apr;220(3):591-8. doi: 10.1007/s00213-011-2513-z. Epub 2011 Sep 24. Psychopharmacology (Berl). 2012. PMID: 21947320 Clinical Trial.

8

A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders.

Hasanzadeh E, Mohammadi MR, Ghanizadeh A, Rezazadeh SA, Tabrizi M, Rezaei F, Akhondzadeh S. Hasanzadeh E, et al. Among authors: tabrizi m. Child Psychiatry Hum Dev. 2012 Oct;43(5):674-82. doi: 10.1007/s10578-012-0292-3. Child Psychiatry Hum Dev. 2012. PMID: 22392415 Clinical Trial.

9

Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial.

Modabbernia A, Sohrabi H, Nasehi AA, Raisi F, Saroukhani S, Jamshidi A, Tabrizi M, Ashrafi M, Akhondzadeh S. Modabbernia A, et al. Among authors: tabrizi m. Psychopharmacology (Berl). 2012 Oct;223(4):381-8. doi: 10.1007/s00213-012-2729-6. Epub 2012 May 3. Psychopharmacology (Berl). 2012. PMID: 22552758 Clinical Trial.

10

Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.

Jafarinia M, Mohammadi MR, Modabbernia A, Ashrafi M, Khajavi D, Tabrizi M, Yadegari N, Akhondzadeh S. Jafarinia M, et al. Among authors: tabrizi m. Hum Psychopharmacol. 2012 Jul;27(4):411-8. doi: 10.1002/hup.2242. Hum Psychopharmacol. 2012. PMID: 22806822 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters